Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study

This publication has 13 references indexed in Scilit:

• Isolation and In vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: Functional and molecular characterisation for their use in adoptive immunotherapy
  European Journal Of Cancer, 1994
• Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer
  Lung Cancer, 1993
• Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.
  Journal of Clinical Oncology, 1992
• Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.
  Journal of Clinical Oncology, 1991
• Chest wall involvement by lung cancer: Computed tomographic detection and results of operation
  The Annals of Thoracic Surgery, 1991
• Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.
  Journal of Clinical Oncology, 1990
• CD 16 surface molecules regulate the cytolytic function of CD3⁻CD16⁺ human natural killer cells
  International Journal of Cancer, 1989
• TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER
  The Lancet, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.
  The Journal of Experimental Medicine, 1983